Otonomy works to bring new treatment options to patients with hearing and balance disorders. Otonomy’s technology enables drugs to reach targets effectively and safely within the protected inner ear. The company is developing multiple novel therapeutics to treat tinnitus, Ménière’s disease, and hearing loss.

IPO August 2014 (NASDAQ: OTIC)